Molecular Modeling and Structure-based Drug Discovery Studies of Aldose Reductase Inhibitors
- 1 January 2002
- journal article
- Published by Chem-Bio Informatics Society in Chem-Bio Informatics Journal
- Vol. 2, 74-85
- https://doi.org/10.1273/cbij.2.74
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- What is oxidative stress?Metabolism, 2000
- Negative consequences of glycationMetabolism, 2000
- Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.Diabetes, 1999
- Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans.Diabetes Care, 1999
- Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projectionsDiabetes Care, 1998
- Protein kinase C activation and the development of diabetic complications.Diabetes, 1998
- Diabetes Complications: Why Is Glucose Potentially Toxic?Science, 1996
- Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β InhibitorScience, 1996
- Aldose reductase inhibitors and their potential for the treatment of diabetic complicationsTrends in Pharmacological Sciences, 1994
- Syntheses of tolrestat analogs containing additional substituents in the ring and their evaluation as aldose reductase inhibitors. Identification of potent, orally active 2-fluoro derivativesJournal of Medicinal Chemistry, 1991